Canada Post Corporation Pension Plan’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.79M Sell
406,760
-9,791
-2% -$256K 0.34% 58
2026
Q1
$11.7M Buy
416,551
+26,423
+7% +$703K 0.47% 46
2025
Q4
$9.71M Buy
390,128
+47,286
+14% +$1.19M 0.37% 60
2025
Q3
$8.18M Buy
342,842
+185,704
+118% +$4.58M 0.36% 63
2025
Q2
$3.81M Buy
+157,138
New +$3.66M 0.22% 89
2025
Q1
Sell
-252,770
Closed -$6.71M 337
2024
Q4
$6.71M Buy
+252,770
New +$6.86M 0.4% 61

Other funds holding PFE

Canada Post Corporation Pension Plan's PFE Position: Q2 2026 in Review

Canada Post Corporation Pension Plan reduced its Pfizer (PFE) stake by 2.4% in Q2 2026, selling an estimated $256K and leaving 406,760 shares worth $9.79M. The position accounts for 0.34% of the portfolio, ranked #58.

Canada Post Corporation Pension Plan first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $11.7M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Canada Post Corporation Pension Plan held 406,760 shares of Pfizer worth $9.79M as of Q2 2026.
  • Canada Post Corporation Pension Plan sold 9,791 Pfizer shares in Q2 2026, an estimated $256K.
  • Pfizer made up 0.34% of Canada Post Corporation Pension Plan's portfolio in Q2 2026, its #58 holding.
  • Canada Post Corporation Pension Plan first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • Canada Post Corporation Pension Plan's Pfizer position peaked at $11.7M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Canada Post Corporation Pension Plan's 13F filing for Q2 2026, filed 15 Jul 2026.